Clinical Guideline InSights
The 2026 Evaluation and Management of N2+ Non-Small Cell Lung Cancer consensus document, highlighting key consensus statements on staging, use of chemoimmunotherapy, resectability, and more. * Evaluation and Management of N2+ Non-Small Cell Lung Cancer * American Association for Thoracic Surgery * May 2, 2026 * Guideline Summary: https://www.guidelinecentral.com/guideline/5216039/ [https://www.guidelinecentral.com/guideline/5216039/] * Full-Text: https://www.jtcvs.org/article/S0022-5223(26)00899-8/pdf [https://www.jtcvs.org/article/S0022-5223(26)00899-8/pdf]
41 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Clinical Guideline InSights-Community!